Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm A Martin

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|August 1, 2025
Clonal Expansion and Diversification of Germinal Center and Memory B Cell Responses to Booster Immunization in PrimatesLachlan P Deimel, Yoshiaki Nishimura, Gabriela S Silva Santos, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopesHarry B Gristick, Harald Hartweger, Yoshiaki Nishimura, et al.
The Journal of Experimental Medicine|August 12, 2025
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopesHarry B Gristick, Harald Hartweger, Yoshiaki Nishimura, et al.
Science Translational Medicine|July 31, 2015
Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infectionTakuya Yamamoto, Rebecca M Lynch, Rajeev Gautam, et al.
Nature|March 15, 2017
Early antibody therapy can induce long-lasting immunity to SHIVYoshiaki Nishimura, Rajeev Gautam, Tae-Wook Chun, et al.
The Journal of Experimental Medicine|November 12, 2014
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variantsFlorian Klein, Lilian Nogueira, Yoshiaki Nishimura, et al.
The Journal of Experimental Medicine|August 27, 2014
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaquesMasashi Shingai, Olivia K Donau, Ronald J Plishka, et al.
Plos Pathogens|January 5, 2017
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization FingerprintingNicole A Doria-Rose, Han R Altae-Tran, Ryan S Roark, et al.
Science (New York, N.Y.)|May 11, 2013
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationIvelin S Georgiev, Nicole A Doria-Rose, Tongqing Zhou, et al.
Science Translational Medicine|November 24, 2021
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 EnvAmelia Escolano, Harry B Gristick, Rajeev Gautam, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|August 1, 2025
Clonal Expansion and Diversification of Germinal Center and Memory B Cell Responses to Booster Immunization in PrimatesLachlan P Deimel, Yoshiaki Nishimura, Gabriela S Silva Santos, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopesHarry B Gristick, Harald Hartweger, Yoshiaki Nishimura, et al.
The Journal of Experimental Medicine|August 12, 2025
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopesHarry B Gristick, Harald Hartweger, Yoshiaki Nishimura, et al.
Science Translational Medicine|July 31, 2015
Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infectionTakuya Yamamoto, Rebecca M Lynch, Rajeev Gautam, et al.
Nature|March 15, 2017
Early antibody therapy can induce long-lasting immunity to SHIVYoshiaki Nishimura, Rajeev Gautam, Tae-Wook Chun, et al.
The Journal of Experimental Medicine|November 12, 2014
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variantsFlorian Klein, Lilian Nogueira, Yoshiaki Nishimura, et al.
The Journal of Experimental Medicine|August 27, 2014
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaquesMasashi Shingai, Olivia K Donau, Ronald J Plishka, et al.
Plos Pathogens|January 5, 2017
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization FingerprintingNicole A Doria-Rose, Han R Altae-Tran, Ryan S Roark, et al.
Science (New York, N.Y.)|May 11, 2013
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationIvelin S Georgiev, Nicole A Doria-Rose, Tongqing Zhou, et al.
Science Translational Medicine|November 24, 2021
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 EnvAmelia Escolano, Harry B Gristick, Rajeev Gautam, et al.
Pageof 7